Literature DB >> 12908069

Coinfection with Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured plaques associated with acute myocardial infarction.

Maria de Lourdes Higuchi1, Marcia Martins Reis, Nádia Vieira Sambiase, Suely Aparecida Pinheiro Palomino, Jussara Bianchi Castelli, Paulo Sampaio Gutierrez, Vera Demarchi Aiello, José Antonio Franchini Ramires.   

Abstract

OBJECTIVE: To study atheromas, Mycoplasma pneumoniae (M. pneumoniae), and Chlamydia pneumoniae (C. pneumoniae).
METHODS: C. pneumoniae was studied with immunohistochemistry and M. pneumoniae with in situ hybridization (ISH), in segments of coronary arteries (SCA) as follows: group A - thrombosed ruptured plaques (TRP) of 23 patients who died due to acute myocardial infarction (AMI); group B - 23 nonruptured plaques (NRP) of group A patients; group C - NRP of 11 coronary patients who did not die due to AMI; and group D - 11 SCA from patients with dilated cardiomyopathy or Chagas' disease without atherosclerosis.
RESULTS: The mean number of C. pneumoniae+ cells/400x in groups A, B, C, and D was, respectively, 3.3 +/- 3.6; 1.0 +/- 1.3; 1.2 +/- 2.4; and 0.4 +/- 0.3; and the percentage of M. pneumoniae area was, respectively, 3.9 +/- 3.5; 1.5 +/- 1.6; 0.9 +/- 0.9; and 0.4 +/- 0.2. More M. pneumoniae and C. pneumoniae were found in of group A than in group B (P<0.01). Good correlation was seen between the area of the vessel and the M. pneumoniae area in the plaque (r = 0.46; P=0.001) and between C. pneumoniae+ cells and CD4+ T lymphocytes (r = 0.42; P<0.01). The number of C. pneumoniae+ cells correlated with CD20+ B cells (r=0.48; P<0.01).
CONCLUSION: M. pneumoniae and C. pneumoniae are more frequently found in TRP correlate with the intensity of the inflammation and diameter of the vessel (positive remodeling).

Entities:  

Mesh:

Year:  2003        PMID: 12908069     DOI: 10.1590/s0066-782x2003000900001

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  7 in total

1.  Atherosclerosis, inflammation and Chlamydia pneumoniae.

Authors:  Giovanni Fazio; Maria Giovino; Alessandro Gullotti; Daniela Bacarella; Giuseppina Novo; Salvatore Novo
Journal:  World J Cardiol       Date:  2009-12-31

Review 2.  Infectious burden and atherosclerosis: A clinical issue.

Authors:  Rosa Sessa; Marisa Di Pietro; Simone Filardo; Ombretta Turriziani
Journal:  World J Clin Cases       Date:  2014-07-16       Impact factor: 1.337

3.  Absence of Atherosclerosis in Chagas' Disease: The Role of Trypanosoma Cruzi Transialidase.

Authors:  Maria de Lourdes Higuchi
Journal:  Arq Bras Cardiol       Date:  2020-12       Impact factor: 2.000

4.  Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice.

Authors:  Sueli B Damy; Maria L Higuchi; Jorge Timenetsky; Márcia M Reis; Suely P Palomino; Renata N Ikegami; Fabiana P Santos; Junko T Osaka; Luiz P Figueiredo
Journal:  BMC Microbiol       Date:  2009-09-10       Impact factor: 3.605

5.  Role of NOD2/CARD15 in coronary heart disease.

Authors:  Nour Eddine El Mokhtari; Stephan J Ott; Almut Nebel; Arne Schäfer; Philip Rosenstiel; Matti Förster; Michael Nothnagel; Rüdiger Simon; Stefan Schreiber
Journal:  BMC Genet       Date:  2007-11-02       Impact factor: 2.797

6.  Infectious agents is a risk factor for myxomatous mitral valve degeneration: A case control study.

Authors:  Marcos Gradim Tiveron; Pablo Maria Alberto Pomerantzeff; Maria de Lourdes Higuchi; Marcia Martins Reis; Jaqueline de Jesus Pereira; Joyce Tieko Kawakami; Renata Nishiyama Ikegami; Carlos Manuel de Almeida Brandao; Fabio Biscegli Jatene
Journal:  BMC Infect Dis       Date:  2017-04-21       Impact factor: 3.090

Review 7.  Thrombosis associated with mycoplasma pneumoniae infection (Review).

Authors:  Jingwei Liu; Yumei Li
Journal:  Exp Ther Med       Date:  2021-07-07       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.